1. Home
  2. RAMP vs OGN Comparison

RAMP vs OGN Comparison

Compare RAMP & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$24.32

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.35

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAMP
OGN
Founded
2018
1923
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
RAMP
OGN
Price
$24.32
$7.35
Analyst Decision
Buy
Hold
Analyst Count
5
5
Target Price
$35.60
$14.10
AVG Volume (30 Days)
722.8K
6.2M
Earning Date
02-05-2026
02-12-2026
Dividend Yield
N/A
1.08%
EPS Growth
86614.23
N/A
EPS
1.05
0.72
Revenue
$795,572,000.00
$6,216,000,000.00
Revenue This Year
$11.07
N/A
Revenue Next Year
$9.11
N/A
P/E Ratio
$23.26
$10.26
Revenue Growth
9.18
N/A
52 Week Low
$21.71
$6.18
52 Week High
$35.20
$17.23

Technical Indicators

Market Signals
Indicator
RAMP
OGN
Relative Strength Index (RSI) 39.32 32.34
Support Level $22.69 $6.50
Resistance Level $25.25 $8.48
Average True Range (ATR) 1.17 0.40
MACD 0.09 -0.22
Stochastic Oscillator 39.61 22.47

Price Performance

Historical Comparison
RAMP
OGN

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: